Some of the world’s biggest names in interventional cardiology and structural heart disease gathered in Washington, D.C., for the four-day event. 

Two new studies evaluated the long-term impact of choosing TAVR when low-risk patients present with severe aortic stenosis. 

Researchers say their new analysis, based on five years of U.S. data, highlights just how important it is to keep post-TAVR PPMI rates to a minimum. 

The doctor appealed the hospital's decision in hopes of returning to work, but that appeal was ultimately denied. 

Carrie Redick, an ICU nurse for nearly 20 years, said understanding more about financial data improved her ability to acquire funding and other resources for her program when necessary. 

Cerebral protection devices, designed to limit the risk of stroke during transcatheter aortic valve replacement, may be especially helpful when patients undergo valve-in-valve TAVR.

The veteran cardiologist had been worried that cerebral protection devices were only being used to treat TAVR patients with specific insurance plans. The lawsuit has now been resolved to the “mutual satisfaction” of both parties.

Alain Cribier, MD, a veteran interventional cardiologist out of France, died at the age of 79. The procedure he helped put on the map is arguably cardiology's most significant breakthrough in the last several decades.